Pillstats
Rx only · Tablet, Extended Release · Oral

Alfuzosin Hydrochloride

Alfuzosin Hydrochloride

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)17300
US makers7 labelers
Packages29
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 10 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.032$0.064$0.096$0.128Dec 2025Apr 2026Jul 2026
$0.108
Latest avg · Jul 22, 2026
+0%
Since Dec 17, 2025
7
Active US suppliers
52%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.9K7.9K12K16K2025 Q12025 Q22025 Q32025 Q42026 Q1
11K
Rx · 2026 Q1
493K
Units dispensed
-22%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager10SUPPLYING
Exelan Pharmaceuticals, Inc.unknown5SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown5SUPPLYING
Aphena Pharma Solutions - Tennessee, LLCunknown3SUPPLYING
Unichem Pharmaceuticals (USA), Inc.unknown3SUPPLYING
Northwind Health Company, LLCunknown2SUPPLYING
Apotex Corp.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 5, 2017
    RECALLRecall (Class II): Alfuzosin Hydrochloride Extended-release Tablets, 10 mg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical…

    Presence of Foreign Substance: consumer complaint for foreign matter embedded in the tablet identified as a broken piece of wire rope from the manufacturing equipment. — Recalling firm: Sun Pharmaceutical Industries, Inc. — Nationwide in the USA and Puerto Rico.